Hearing Loss, Hearing Products, Patient Care, Practice Building

Popular

Study Shows Hair Cell Regrowth with New Drug

A new approach, published in “Cell Reports,” to regenerate inner ear sensory hair cells is said to lay the groundwork for treating chronic noise-induced hearing loss by the company, Frequency Therapeutics, and its co-founders who are drawing on research from Brigham and Women's Hospital (BWH), Harvard Medical School, Mass Eye and Ear Infirmary, and MIT. The program is expected to progress to into human clinical trials within the next 18 months.

Prevention

Latest

3M Mass Tort Now Includes Over 200,000 People, ‘Star-Tribune’ Reports

“The Minneapolis Star-Tribune” reports that over 200,000 people have joined a mass tort against 3M, alleging that Aearo’s Combat Arms earplugs “were knowingly defective, imperceptibly loosening and leaking in noise.” The Combat earplugs were acquired by 3M as part of its $1.2 billion purchase of Aearo Technologies in 2008.

Tinnitus

Latest

IU Cancer Center Researcher Awarded $5.7 Million Grant to Study Chemo-Induced Hearing Loss

Nearly 6 million patients globally are diagnosed with a cancer each year in which first-line therapy potentially includes highly toxic, platinum-based chemotherapies. While the treatment may lead to hearing loss, ringing in the ears, numbness in hands and feet, and other side effects, it is the only proven cure for the vast majority of testicular cancer patients.

Practice Building

Latest